University of Maryland, Baltimore: Breast Neoplasms trials

The registry lists 15 Breast Neoplasms studies with University of Maryland, Baltimore as lead sponsor. 3 are open to participants now and 6 have results posted.

Phase 1 3Phase 2 6No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerNot yet recruitingNCT07374796
• Metabotyping of Broccoli Microgreen in Obese Breast Cancer SurvivorsRecruitingNCT07032545Not applicable
• GammaPod Dose Escalation Radiation for Early Stage Breast CancerRecruitingNCT04234386Not applicable
• GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese PatientsTerminatedNCT02095184Not applicableResults posted
• 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.TerminatedNCT02000596Phase 2Results posted
• Breast Cup Immobilization Device II (GCC 1047)CompletedNCT01704547Results posted
• Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast CancerTerminatedNCT01499160Phase 2Results posted
• Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTerminatedNCT01234532Phase 2Results posted
• GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and BiomarkersTerminatedNCT01118975Phase 1/2Results posted
• Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessActive, not recruitingNCT05968144Phase 1/2
• 1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast CancerTerminatedNCT02700776
• HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)WithdrawnNCT01924351Phase 2
• Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast CancerCompletedNCT01014715Not applicable
• Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast CancerCompletedNCT00641303Not applicable
• LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNCT00005858Phase 1